Rexulti now in pharmacies, a new treatment for schizophrenia and MDD

Rexulti: New treatment for schizophrenia and major depressive disorder approved and released by FDA

On July 10, the U.S. Food and Drug Administration approved Rexulti (brexpiprazole) tablets to treat adults with schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with major depressive disorder (MDD).